PGP and acute myeloid leukemia: Inhibiting Pgp using drugs such as zosuquidar [69], PSC-833 [70], and cyclosporine [71] has been long studied, including several clinical trials, as a mechanism to effectively treat several diseases, such as acute myeloid leukemia (AML) [72].